Gabriel Rodrigues

Dr. Gabriel Rodrigues

University of Milan, Milan, Lombardy, Italy
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2022 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
RPRonney Panerai
Ronney Panerai
PBPatrice Brassard
Patrice Brassard
JBJoel S Burma
Joel S Burma
Pedro CastroPedro Castro
Pedro Castro
JCJurgen Ahr Claassen
Jurgen Ahr Claassen
NGNicolai Goettel
Nicolai Goettel
Cerebral autoregulation (CA) refers to the control of cerebral tissue blood flow (CBF) in response to changes in perfusion pressure. Due to the challenges of measuring intracranial pressure, CA is often described as the relationship between mean arterial pressure (MAP) and CBF. Dynamic CA (dCA) can be assessed using multiple techniques, with transfer function analysis (TFA) being the most common. A 2016 white paper by members of an international Cerebrovascular Research Network (CARNet) that is focused on CA strove to improve TFA standardization by way of introducing data acquisition, analysis, and reporting guidelines. Since then, additional evidence has allowed for the improvement and refinement of the original recommendations, as well as for the inclusion of new guidelines to reflect recent advances in the field. This second edition of the white paper contains more robust, evidence-based recommendations, which have been expanded to address current streams of inquiry, including optimizing MAP variability, acquiring CBF estimates from alternative methods, estimating alternative dCA metrics, and incorporating dCA quantification into clinical trials. Implementation of these new and revised recommendations is important to improve the reliability and reproducibility of dCA studies, and to facilitate inter-institutional collaboration and the comparison of results between studies.

Verified
Journal Article
Open access
PDF file
CBChiara Bellocchi
Chiara Bellocchi
ACAngelica Carandina
Angelica Carandina
BMBeatrice Montinaro
Beatrice Montinaro
ETElena Targetti
Elena Targetti
LFLudovico Furlan
Ludovico Furlan
NMNicola Montano
Nicola Montano
The autonomic nervous system (ANS) and the immune system are deeply interrelated. The ANS regulates both innate and adaptive immunity through the sympathetic and parasympathetic branches, and an imbalance in this system can determine an altered inflammatory response as typically observed in chronic conditions such as systemic autoimmune diseases. Rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis all show a dysfunction of the ANS that is mutually related to the increase in inflammation and cardiovascular risk. Moreover, an interaction between ANS and the gut microbiota has direct effects on inflammation homeostasis. Recently vagal stimulation techniques have emerged as an unprecedented possibility to reduce ANS dysfunction, especially in chronic diseases characterized by pain and a decreased quality of life as well as in chronic inflammation.

1 October 2021 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
Gabriel RodriguesGabriel Rodrigues
Gabriel Rodrigues
EFElisa M. Fiorelli
Elisa M. Fiorelli
LFLudovico Furlan
Ludovico Furlan
NMNicola Montano
Nicola Montano
ETEleonora Tobaldini
Eleonora Tobaldini

1 August 2019 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
Gabriel RodriguesGabriel Rodrigues
Gabriel Rodrigues
ETEleonora Tobaldini
Eleonora Tobaldini
CBChiara Bellocchi
Chiara Bellocchi
ASAlessandro Santaniello
Alessandro Santaniello
MCMonica Caronni
Monica Caronni
NMNicola Montano
Nicola Montano

1 July 2021 in Experimental Gerontology
Verified
Journal Article
Closed access
Gabriel RodriguesGabriel Rodrigues
Gabriel Rodrigues
PLPedro Dal Lago
Pedro Dal Lago
PSPedro Paulo da Silva Soares
Pedro Paulo da Silva Soares

15 March 2022 in Frontiers in Neuroscience
Verified
Journal Article
Open access
ACAngelica Carandina
Angelica Carandina
GLGiulia Lazzeri
Giulia Lazzeri
Gabriel RodriguesGabriel Rodrigues
Gabriel Rodrigues
GFGiulia Franco
Giulia Franco
EMEdoardo Monfrini
Edoardo Monfrini
Eleonora TobaldiniEleonora Tobaldini
Eleonora Tobaldini
Evidence from clinical practice suggests that PD patients with the Glucocerebrosidase gene mutations (GBA-PD) are characterized by more severe dysautonomic symptoms than patients with idiopathic PD (iPD). Therefore, an accurate assessment of cardiovascular autonomic control (CAC) is necessary to clarify the role of GBA mutations in the pathophysiology of PD. We evaluated the CAC at rest and during orthostatic challenge of 15 iPD, 15 GBA-PD and 15 healthy controls (CTR). ECG and respiration were recorded in supine position and during active standing. The analysis of Heart Rate Variability (HRV) was performed on ECG recordings using two different approaches, linear spectral analysis and non-linear symbolic analysis. GBA-PD patients presented more frequently an akinetic-rigid phenotype and cognitive dysfunction than iPD patients. Both iPD and GBA-PD group were characterized by a lower spectral HRV than CTR group. At rest, the GBA-PD group was characterized by a lower parasympathetic modulation and a shift of the sympathovagal balance toward a sympathetic predominance compared to the CTR group. Moreover, the GBA-PD patients presented a lower HR increment and a lower or absent reduction of the vagal modulation in response to the active standing than iPD patients. Lastly, the cardiovascular autonomic dysfunction in PD patients was associated with longer disease duration, and with the occurrence of REM sleep behavior disorder and constipation. Our findings suggest a more severe impairment of the CAC in PD patients with GBA mutations. These results and further studies on the role of GBA mutations could allow a stratification based on cardiovascular risk in PD patients and the implementation of specific prevention programs.